CClinicalTrials.gg
CompletedNCT07561151ALATRIUMUpdated May 1, 2026

Assessment of Left Atrial Size and Function by Cardiac Magnetic Resonance

An observational study in Cardiac Magnetic Resonance, sponsored by Istituto Auxologico Italiano. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by Istituto Auxologico Italiano · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

Left atrial (LA) size and function are powerful prognostic markers in a variety of clinical conditions. Cardiac magnetic resonance (CMR) is considered the gold-standard to assess the volumes of heart chambers by contouring cavity borders at end-diastole and end-systole from a short-axis cine stack. This method is routinely used to measure ventricular volumes and ejection fraction, but has never been implemented for LA volume measurements, due to the need of a significant lengthening of both CMR acquisition and post-processing times. Current CMR guidelines do not provide any specific recommendation on LA imaging in daily routine, and LA volume is usually evaluated by using the biplane area-length algorithm in standard cine long-axis images. Yet, the latter methodology implies geometric assumptions about the LA shape that are often not fulfilled in routine patients. Moreover, the standard long-axis views are oriented according to the major axis of the left ventricle (LV), which lies in a plane with a different spatial orientation compared with the LA. As a result, standard long-axis views optimized according to the maximal LV length commonly foreshorten the LA and therefore underestimate its size.

Accordingly, a previous echocardiographic study showed that long-axis views focused on the LA were more accurate to derive LA maximal volume vs. standard long-axis views.

Differently from echocardiography, CMR allows to orientate images during acquisition process with no dependency from acoustic windows. Capturing the true LA long-axis by focused imaging is therefore more feasible with CMR vs. two-dimensional echocardiography. Compared to current CMR practice, implementation of focused LA long-axis views might result in improved accuracy of LA volumes estimation with no significant delay on acquisition times (Figure).

LA dysfunction, as assessed by deformation analysis, is emerging as an early prognostic marker in several cardiac diseases. At present, standard long-axis cine images are used for CMR feature tracking (CMR-FT), which allows the assessment of atrial phasic functions. Of core importance, CMR-FT derived strain parameters [i.e., LA total strain (εs), conduit strain (εe), and booster strain (εa)] are sensible to plan orientation and might be affected by foreshortening.

Current CMR protocols use long-axis cine images oriented on the LV long axis and may systematically underestimate LA size and function. We hypothesize that LA-focused long-axis cine images at CMR are more accurate in estimating LA volumes and function than current practice.

02

Conditions studied

  • Cardiac Magnetic Resonance

Keywords

  • Left atrium
  • Cardiac Magnetic Resonance
03

In context

Lead sponsor

Istituto Auxologico Italiano is the lead sponsor of 196 studies on the registry; 78 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients who undergo clinically indicated CMR

Inclusion criteria

  • Older than 18 years
  • Clinically indicated CMR with diagnostic image quality
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Unwillingness to participate in the study
  • Congenital heart disease
  • Pregnancy or breast-feeding
  • Any other contraindication to CMR study
  • Heart transplantation
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (actual)
Patient registry
No

Groups and cohorts

  • Clinically indicated CMR

    Patients who undergo clinically indicated CMR

    Diagnostic Test: CMR scan

Interventions

  • Diagnostic testCMR scan

    CMR image acquisition and analysis of the left atrium

06

What researchers measure

Primary outcomes

  1. Left atrial volume - focused long-axis views

    Left atrial volume obtained by focused long-axis imaging

    Time frame: Baseline

  2. Left atrial volume - standard long axis views

    Left atrial volume obtained by standard long-axis imaging

    Time frame: Baseline

  3. Duration of acquisition of focused long-axis views of left atrium

    Duration of acquisition of focused long-axis views of left atrium in minutes

    Time frame: Baseline

  4. Longitudinal strain - focused long-axis views

    CMR Feature Tracking (CMR-FT) strain obtained by focused long-axis imaging

    Time frame: Baseline

  5. Longitudinal strain - standard long-axis views

    CMR Feature Tracking (CMR-FT) strain obtained by standard long-axis imaging

    Time frame: Baseline

07

Study locations

1 site
  • Policlinico San Donato, IRCCS
    San Donato Milanese, 20100, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07561151
Lead sponsor
Istituto Auxologico Italiano
Responsible party
Sponsor
First posted
May 1, 2026
Start date
May 25, 2021
Primary completion
Aug 25, 2025
Completion
Aug 25, 2025
Last update
May 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion